{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:31:30Z","timestamp":1790281890709,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["16K09893"],"award-info":[{"award-number":["16K09893"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["18K161148"],"award-info":[{"award-number":["18K161148"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1963-2","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T13:02:27Z","timestamp":1565096547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice"],"prefix":"10.1186","volume":"21","author":[{"given":"Sho","family":"Sendo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Saegusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-638X","authenticated-orcid":false,"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"issue":"1","key":"1963_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/14397595.2016.1173816","volume":"27","author":"Mineto Ota","year":"2016","unstructured":"Ota M, Iwasaki Y, Harada H, Sasaki O, Nagafuchi Y, Nakachi S, et al. Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease. Mod Rheumatol. 2016. \n                    https:\/\/doi.org\/10.3109\/14397595.2016.1173816\n                    \n                  .","journal-title":"Modern Rheumatology"},{"issue":"Suppl 2","key":"1963_CR2","doi-asserted-by":"publisher","first-page":"i70","DOI":"10.1136\/annrheumdis-2011-200595","volume":"71","author":"Y Tanaka","year":"2012","unstructured":"Tanaka Y, Maeshima K, Yamaoka K. In vitro and in vivo analysis of JAK inhibitor in rheumatoid arthritis. Ann Rheum Dis. 2012;71(Suppl 2):i70\u20134. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2011-200595\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1963_CR3","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/rheumatology\/key188","volume":"57","author":"Kazuhiro Kurasawa","year":"2018","unstructured":"Kurasawa K, Arai S, Namiki Y, Tanaka A, Takamura Y, Owada T, et al. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. Rheumatology (Oxford). 2018. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/key188\n                    \n                  .","journal-title":"Rheumatology"},{"key":"1963_CR4","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150.","journal-title":"Nat Commun"},{"key":"1963_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41232-018-0076-7","volume":"38","author":"S Sendo","year":"2018","unstructured":"Sendo S, Saegusa J, Morinobu A. Myeloid-derived suppressor cells in non-neoplastic inflamed organs. Inflamm Regen. 2018;38:19.","journal-title":"Inflamm Regen"},{"key":"1963_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454\u201360.","journal-title":"Nature"},{"key":"1963_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.smim.2006.03.007","volume":"18","author":"S Sakaguchi","year":"2006","unstructured":"Sakaguchi S, Sakaguchi N, Yoshitomi H, Hata H, Takahashi T, Nomura T. Spontaneous development of autoimmune arthritis due to genetic anomaly of T cell signal transduction: part 1. Semin Immunol. 2006;18:199\u2013206.","journal-title":"Semin Immunol"},{"key":"1963_CR8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4049\/jimmunol.1303255","volume":"193","author":"A Shiomi","year":"2014","unstructured":"Shiomi A, Usui T, Ishikawa Y, Shimizu M, Murakami K, Mimori T. GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice. J Immunol. 2014;193:849\u201359.","journal-title":"J Immunol"},{"issue":"12","key":"1963_CR9","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.40231","volume":"69","author":"S Sendo","year":"2017","unstructured":"Sendo S, Saegusa J, Okano T, Takahashi S, Akashi K, Morinobu A. CD11b+Gr-1dim tolerogenic dendritic cell-like cells are expanded in interstitial lung disease in SKG mice. Arthritis Rheumatol. 2017;69(12):2314\u201327.","journal-title":"Arthritis Rheumatol"},{"key":"1963_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/art.39007","volume":"67","author":"K Nishimura","year":"2015","unstructured":"Nishimura K, Saegusa J, Matsuki F, Akashi K, Kageyama G, Morinobu A. Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates arthritis in SKG mice. Arthritis Rheumatol. 2015;67:893\u2013902.","journal-title":"Arthritis Rheumatol"},{"key":"1963_CR11","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1084\/jem.20041758","volume":"201","author":"H Yoshitomi","year":"2005","unstructured":"Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T, Sakihama T, et al. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med. 2005;201:949\u201360.","journal-title":"J Exp Med"},{"key":"1963_CR12","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.191.5.847","volume":"191","author":"R Nishikomori","year":"2000","unstructured":"Nishikomori R, Ehrhardt RO, Strober W. T helper type 2 cell differentiation occurs in the presence of interleukin 12 receptor beta2 chain expression and signaling. J Exp Med. 2000;191:847\u201358.","journal-title":"J Exp Med"},{"key":"1963_CR13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","volume":"176","author":"K Inaba","year":"1992","unstructured":"Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor. J Exp Med. 1992;176:1693\u2013702.","journal-title":"J Exp Med"},{"key":"1963_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bbrc.2011.12.156","volume":"418","author":"H Yoshida","year":"2012","unstructured":"Yoshida H, Kimura A, Fukaya T, Sekiya T, Morita R, Shichita T, et al. Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation. Biochem Biophys Res Commun. 2012;418:234\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"1963_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/art.20765","volume":"52","author":"C Turesson","year":"2005","unstructured":"Turesson C, Matteson EL, Colby TV, Vuk-Pavlovic Z, Vassallo R, Weyand CM, et al. Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthritis Rheum. 2005;52:73\u20139.","journal-title":"Arthritis Rheum"},{"key":"1963_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/08923970600809389","volume":"28","author":"Y Shimizu","year":"2006","unstructured":"Shimizu Y, Kuwabara H, Ono A, Higuchi S, Hisada T, Dobashi K, et al. Intracellular Th1\/Th2 balance of pulmonary CD4(+) T cells in patients with active interstitial pneumonia evaluated by serum KL-6. Immunopharmacol Immunotoxicol. 2006;28:295\u2013304.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1963_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1034\/j.1399-3003.1999.14c16.x","volume":"14","author":"T Yoshinouchi","year":"1999","unstructured":"Yoshinouchi T, Ohtsuki Y, Ueda R, Sato S, Ueda N. Myofibroblasts and S-100 protein positive cells in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial pneumonia. Eur Respir J. 1999;14:579\u201384.","journal-title":"Eur Respir J"},{"issue":"6","key":"1963_CR18","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/art.34329","volume":"64","author":"K Maeshima","year":"2012","unstructured":"Maeshima K, Yamaoka K, Kubo S, Nakano K, Iwata S, Saito K, et al. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-\u03b3 and interleukin-17 production by human CD4+ T cells. Arthritis Rheum. 2012;64(6):1790\u20138.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1963_CR19","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1136\/annrheumdis-2013-203756","volume":"73","author":"S Kubo","year":"2014","unstructured":"Kubo S, Yamaoka K, Kondo M, Yamagata K, Zhao J, Iwata S, et al. The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells. Ann Rheum Dis. 2014;73(12):2192\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1963_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.trsl.2016.11.006","volume":"188","author":"PPC Boor","year":"2017","unstructured":"Boor PPC, de Ruiter PE, Asmawidjaja PS, Lubberts E, van der Laan LJW, Kwekkeboom J. JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa. Transl Res. 2017;188:67\u201379.","journal-title":"Transl Res"},{"issue":"7","key":"1963_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1476-9255-7-41","volume":"11","author":"DM Meyer","year":"2010","unstructured":"Meyer DM, Jesson MI, Li X, Elrick MM, Funckes-Shippy CL, Warner JD, et al. Anti-inflammatory activity and neutrophil reductions mediated by the JAK1\/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis. J Inflamm (Lond). 2010;11(7):41.","journal-title":"J Inflamm (Lond)"},{"issue":"1","key":"1963_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","volume":"32","author":"T Condamine","year":"2011","unstructured":"Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 2011;32(1):19\u201325.","journal-title":"Trends Immunol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1963-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1963-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1963-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T23:11:09Z","timestamp":1596582669000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1963-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1963"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1963-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"21 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal protocols were received prior to the approval of the institutional review board, and all procedures were performed in accordance with the recommendations of the Institutional Animal Care Committee of Kobe University.This study contains no human data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}